Resistance to guanidine and D-HBB is an inherent characteristic of hepatitis A virus, though this does not exclude it from the picornavirus family.
Answers are grounded in this paper and cite their sources.
HAV resistance to guanidine and D-HBB is inherent; leaves open picornavirus classification and targeted antiviral strategies.
Replication of hepatitis A virus (HAV) in the human hepatoma-derived PLC/PRF/5 cell line was neither inhibited in the presence of various concentrations of guanidine or D-2-(alpha-hydroxybenzyl)benzimidazole (D-HBB), nor were the two chemicals effective in combination. Under identical conditions, however, replication of poliovirus type 1 was inhibited. Tracer experiments with radiolabelled guanidine and D-HBB also furnished no evidence that the two antiviral substances were metabolized gradually to inactive derivatives in PLC/PRF/5 cells. Therefore, it is concluded that resistance to the action of guanidine and D-HBB is an inherent characteristic of HAV. However, the insensitivity of HAV to these drugs does not exclude the virus from the family of picornaviruses.
No takes yet. Share an insight, caveat, or question.
Siegl et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: